The relationship between systemic inflammatory response, screen detection and outcome in colorectal cancer

Author:

Johnstone Mark S.1ORCID,McSorley Steven T.1,McMillan Donald C.1,Horgan Paul G.1,Mansouri David1

Affiliation:

1. Academic Unit of Surgery University of Glasgow, Glasgow Royal Infirmary Glasgow UK

Abstract

AbstractAimA raised systemic inflammatory response correlates with poorer colorectal cancer (CRC) outcomes. Faecal immunochemical test bowel screening aims to detect early‐stage disease. We assessed the relationship between systemic inflammatory response, screen detection and CRC survival.MethodA retrospective, observational cohort study compared screen‐detected and non‐screen‐detected CRC patients undergoing resection. Systemic inflammatory response was measured using lymphocyte/monocyte, neutrophil/lymphocyte and platelet/lymphocyte ratios (LMR, NLR, PLR). Covariables were compared using χ2 testing and survival with Cox regression.ResultsA total of 761 patients were included (326 screen‐detected, 435 non‐screen‐detected). Screen‐detected patients had lower systemic inflammatory response: low (<2.4) LMR (28.8% vs. 44.6%; P < 0.001), moderate (3–5) or high (>5) NLR (26.1% vs. 30.6%, P < 0.001; and 7.7% vs. 19.5%, P < 0.001) and high (>150) PLR (47.2% vs. 64.6%; P < 0.001). Median follow‐up was 63 months. On univariate analysis, non‐screen detection (hazard ratio [HR] 2.346, 95% CI 1.687–3.261; P < 0.001), advanced TNM (P < 0.001), low LMR (HR 2.038, 95% CI 1.514–2.742; P < 0.001), moderate NLR (HR 1.588, 95% CI 1.128–2.235; P = 0.008), high NLR (HR 2.382, 95% CI 1.626–3.491; P < 0.001) and high PLR (HR 1.827, 95% CI 1.326–2.519; P < 0.001) predicted poorer overall survival (OS). Non‐screen detection (HR 2.713, 95% CI 1.742–4.226; P < 0.001), TNM (P < 0.001), low LMR (HR 1.969, 95% CI 1.340–2.893; P < 0.001), high NLR (HR 2.368, 95% CI 1.448–3.875; P < 0.001) and high PLR (HR 2.110, 95% CI 1.374–3.240; P < 0.001) predicted poorer cancer‐specific survival (CSS). On multivariate analysis, non‐screen detection (HR 1.698, 95% CI 1.152–2.503; P = 0.008) and low LMR (HR 1.610, 95% CI 1.158–2.238; P = 0.005) independently predicted poorer OS. Non‐screen detection (HR 1.847, 95% CI 1.144–2.983; P = 0.012) and high PLR (HR 1.578, 95% CI 1.018–2.444; P = 0.041) predicted poorer CSS.ConclusionScreen‐detected CRC patients have a lower systemic inflammatory response. Non‐screen detection and systemic inflammatory response (measured by LMR and PLR respectively) were independent predictors of poorer OS and CSS.

Publisher

Wiley

Subject

Gastroenterology

Reference34 articles.

1. Cancer Research UK. Available from:https://www.cancerresearchuk.org/health‐professional/cancer‐statistics/statistics‐by‐cancer‐type/bowel‐cancer

2. Scottish Bowel Screening Programme—a guide for professionals. Available from:http://www.healthscotland.scot/publications/scottish‐bowel‐screening‐programme‐a‐guide‐for‐professionals

3. Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood

4. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

5. Randomised study of screening for colorectal cancer with faecal-occult-blood test

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3